Predicting TCR-epitope recognition: How good are we?
Cell Genomics · 2025-08 · 5 (8) · 100975
DOI: 10.1016/j.xgen.2025.100975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Genomics, 2025-08. Verfasst von David Gfeller. Beteiligte Einrichtung: Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformati…. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Epitopes, T-Lymphocyte, Epitopes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Accurate TCR-epitope interaction predictions have the potential to unlock the use of TCR repertoires for diagnostics, TCR discovery, and cross-reactivity predictions. In this issue of Cell Genomics, Drost et al.1 developed a streamlined framework for benchmarking such predictions. Careful understanding of the strengths and limitations of existing approaches will be instrumental to improve them and expand the scope of TCR-epitope recognition predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland; Agora Cancer Research Centre, 1011 La…
Förderung
- Swiss National Science Foundation
Zitieren
APA
Gfeller, D. (2025). Predicting TCR-epitope recognition: How good are we?. Cell Genomics, 5(8), 100975. https://doi.org/10.1016/j.xgen.2025.100975
Vancouver
Gfeller D. Predicting TCR-epitope recognition: How good are we?. Cell Genomics. 2025;5(8):100975. doi:10.1016/j.xgen.2025.100975
BibTeX
@article{Gfeller2025,
author = {Gfeller, David},
title = {Predicting TCR-epitope recognition: How good are we?},
journal = {Cell Genomics},
year = {2025},
volume = {5},
number = {8},
pages = {100975},
doi = {10.1016/j.xgen.2025.100975}
}
EUVIMED